Basic and applied research collaboration trends in the pharmaceutical industry

Do firms learn to create value? The case of alliances

Ramin Vandaie

Industrial and Corporate Change, 2022, vol. 31, issue 6, 1387-1396

Abstract: Firms in science-driven industries have traditionally devoted significant resources to basic scientific research. The intensity and outcomes of such investments, however, have changed over time. In this paper, we explore the trends in pharmaceutical companies’ scientific research over a two-decade period between 1990 and 2009. The results of our analyses reveal that the scientific output of large pharmaceutical companies as measured by the publications of company scientists has significantly increased over time. We also find that company scientists’ collaboration with external scientists has increased over time and across the board regardless of company size. Finally, we observe a decline in research and development alliance activities of pharmaceutical companies with the effect being weaker for large firms.

Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1093/icc/dtac025 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:indcch:v:31:y:2022:i:6:p:1387-1396.

Ordering information: This journal article can be ordered from
https://academic.oup.com/journals

Access Statistics for this article

Industrial and Corporate Change is currently edited by Josef Chytry

More articles in Industrial and Corporate Change from Oxford University Press and the Associazione ICC Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK.
Bibliographic data for series maintained by Oxford University Press ().